Biography

Luba Yammine, PhD, APRN, FNP-C is a clinician and research scientist specializing  in the treatment of substance use disorders, including tobacco, alcohol and opioid use disorders (OUD). She is a provider of medication-assisted treatment (MAT) and authorized to prescribe buprenorphine to treat OUD.  She is also a nationally certified Tobacco Treatment Specialist. Her treatment approach is holistic and integrates services to address addiction along with co-occurring mental and medical issues into the comprehensive care of the individual.

As a researcher, Yammine is the Primary Investigator of a CCTS funded clinical trial evaluating exenatide as a potential treatment for smoking cessation. She is also a Primary and a Co-Investigator on several Department of Defense funded projects that focus on treatments for Veterans with substance use disorders.

Yammine has received many awards for academic, clinical, and research achievements, published in peer-reviewed journals and presented at national, regional, and local meetings.

Yammine completed her undergraduate studies in nursing at Texas Woman’s University and Master’s and Doctoral studies at the University of Texas Health Science Center at Houston. She went on to complete postdoctoral training in addiction research at Baylor College of Medicine/Michael E. DeBakey VA Medical Center.

Education

Master’s Degree
Family Nurse Practitioner, University of Texas Health Science Center at Houston
Doctoral Degree
Clinical Research, University of Texas Health Science Center at Houston
Postdoctoral Training
Addictions Research, Baylor College of Medicine/Michael E. DeBakey VA Medical Center

Areas of Interest

Clinical Interests

  • Substance Use Disorders
  • Depression
  • Anxiety
  • Chronic Disease

Research Interests

  • Substance Use: pharmacological and behavioral therapies